[The seroepidemiology of the varicella-zoster virus in children and adolescents]. 1993

A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
Departamento de Medicina Preventiva, Facultad de Medicina, Universidad Autónoma de Madrid.

OBJECTIVE To know the sero-protection level existing of varicella-zoster virus in a population of children and adolescents from Madrid. METHODS To carry out this work we have had a total 560 serum from children and adolescents between 1 and 15 years old. Later to detect the title of antibodies against the varicella zoster virus (IgG VZV), we used enzymo immuno-analysis (PLATEST). RESULTS The 96.5% of them were positive. Distributing this percentage in a similar way for every age, we get 100% at 8, 9, 10, 11 and 15 years old; 97.5% at 5, 6, 7, 12 and 13 years; 95% at 14 years old; 92.5% at 4 years old and 85% at 1 years old and 84% at 2 years old. CONCLUSIONS The prevalence gradually increases with the age, from 20% at 1 year old to 100% at 15, finding the smallest prevalence in 84% to reach rapidly 100%.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002644 Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) Varicella,Chicken Pox
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014505 Urban Population The inhabitants of a city or town, including metropolitan areas and suburban areas. Urban Residence,Urban Spatial Distribution,Distribution, Urban Spatial,Distributions, Urban Spatial,Population, Urban,Populations, Urban,Residence, Urban,Urban Populations,Urban Residences,Urban Spatial Distributions
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus

Related Publications

A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
July 2011, Paediatric and perinatal epidemiology,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
February 2013, Journal of Korean medical science,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
December 2002, Annals of tropical paediatrics,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
September 2012, Iranian journal of microbiology,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
September 2018, Epidemiology and infection,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
December 2000, The Southeast Asian journal of tropical medicine and public health,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
November 2002, European journal of pediatrics,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
June 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
February 1995, Adolescent medicine (Philadelphia, Pa.),
A Gil Miguel, and M L Lasheras Lozano, and R Jiménez García, and M E Calle Purón, and M Santos Santos, and J Rey Calero, and D Martín Hernández
March 2007, Indian journal of medical sciences,
Copied contents to your clipboard!